TWYA Stock Overview
An investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Alibaba Health Information Technology Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$8.45 |
| 52 Week High | HK$14.10 |
| 52 Week Low | HK$6.00 |
| Beta | 1.08 |
| 11 Month Change | -7.65% |
| 3 Month Change | 27.07% |
| 1 Year Change | -16.34% |
| 33 Year Change | -47.19% |
| 5 Year Change | n/a |
| Change since IPO | -83.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| TWYA | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | -5.6% | 0.5% | 0.8% |
| 1Y | -16.3% | -11.4% | 9.1% |
Return vs Industry: TWYA underperformed the German Consumer Retailing industry which returned -13.9% over the past year.
Return vs Market: TWYA underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| TWYA volatility | |
|---|---|
| TWYA Average Weekly Movement | 14.5% |
| Consumer Retailing Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TWYA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: TWYA's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,422 | Difan Shen | www.alihealth.cn |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines.
Alibaba Health Information Technology Limited Fundamentals Summary
| TWYA fundamental statistics | |
|---|---|
| Market cap | €6.93b |
| Earnings (TTM) | €158.79m |
| Revenue (TTM) | €3.73b |
43.6x
P/E Ratio1.9x
P/S RatioIs TWYA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TWYA income statement (TTM) | |
|---|---|
| Revenue | CN¥28.34b |
| Cost of Revenue | CN¥21.78b |
| Gross Profit | CN¥6.56b |
| Other Expenses | CN¥5.35b |
| Earnings | CN¥1.21b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.075 |
| Gross Margin | 23.15% |
| Net Profit Margin | 4.26% |
| Debt/Equity Ratio | 0% |
How did TWYA perform over the long term?
See historical performance and comparison